期刊文献+

单形性亲上皮性肠道T细胞淋巴瘤病例报道并文献复习

Monomorphic epitheliotropic intestinal T-cell lymphoma- case report and literature review
下载PDF
导出
摘要 单形性亲上皮性肠道T细胞淋巴瘤 (Monomorphic Epitheliotropic Intestinal T-cell Lymphoma,MEITL) 是一种起 源于肠道的罕见 T 细胞淋巴瘤,其生物学行为具有侵袭性,预后差,与炎症性肠病 (Inflammatory Bowel Disease,IBD) 和 其它肠道原发 T 细胞淋巴瘤在临床症状、影像和内镜检查方面都有相似之处。该疾病临床少见,往往由于临床和病理医生 认识不足,易导致误诊误治。因此,本文从病理学角度,根据临床实际工作中所遇到的病例,并结合文献复习,系统论述 MEITL的临床流行病学特征、影像和内镜特点以及MEITL的治疗和预后。重点阐述MEITL病理学形态、免疫组织化学、分 子生物学特征以及鉴别诊断,以期帮助病理医生和临床医生对该疾病有更加深入的认识。 Monomorphic epitheliotropic intestinal T-cell lymphoma(MEITL)is a rare T-cell lymphoma originated from the intestine.Its biological behavior is invasive and the prognosis is poor.It is similar to inflammatory bowel disease(IBD)and other intestinal primary T cell lymphomas in clinical symptoms,image and endoscopy.This disease is rare in clinic,and often leads to misdiagnosis and mistreatment due to the lack of understanding of clinical and pathology.Therefore,from the perspective of pathology,according to the cases encountered in clinical practice and combined with literature review,we systematically discuss the clinical epidemiological characteristics,image and endoscopic characteristics,treatment and prognosis of MEITL in this paper,focusing on the pathological morphology,immunohistochemistry,molecular biological characteristics and differential diagnosis,and we hope to help pathologists and clinicians have a deeper understanding about the disease.
作者 苏晓路 张静 毛杰 郭继武 王祥 Su Xiaou;Zhang Jing;Mao Jie;Guo Jiwu;Wang Xiang(Lanzhou University Second Hospital,Lanzhou 730030,Gansu,China)
出处 《生物医学转化》 2023年第1期93-100,共8页 Biomedical transformation
基金 甘肃省重点研发计划项目(21YF5FA124)。
关键词 单形性亲上皮性T细胞淋巴瘤 炎症性肠病 肠道原发T细胞淋巴瘤 病理 鉴别诊断 Monomorphic epitheliotropic intestinal T-cell lymphoma Inflammatory bowel disease Primary intestinal T-cell lymphoma Pathology Differential diagnosis
  • 相关文献

参考文献8

二级参考文献28

  • 1刘思德,姜泊,周殿元.肠病型T细胞淋巴瘤内镜典型形态——附6例临床分析[J].现代消化及介入诊疗,2004,9(2):114-118. 被引量:13
  • 2Cohen J. gpstein-Barr virus infection[J]. N Engl JM ed, 2000; 343(7): 481-492.
  • 3Cohen J, Kimura H, Nakamura S, et al. Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: astatus report and summary of an international meeting, 8-9 September 2008. Ann Oncol, 2009;20(9):1472-1482.
  • 4Kimura H, Hoshino Y, Kanegane H, et al .Clinical and virologic characteristic of chronic active Epsein -Barr virus infection[ J].Blood, 2001; 98(1): 230- 236.
  • 5Cho EY, K i m KH, K i m WS, et al. The spectrum of Epstein-Barr virus-associated lymphoproliferative disease in Korea: Incidenceof disease entities by age groups[J]. J Korean Med Sci, 2008; 23( 1): 185-192.
  • 6Ohshi ma K, K i muraH, Yoshino T, et al. Proposed categorization of pathological states of Egg-associated T/natural killer -cell lymphoproliferative disorder( LPD ) in children and young adults :o -verlap with chronic active EBV infection and infantile ful minant EBV T-LPD[ J]. Pathol Int. 2008: 58( 4): 209-217.
  • 7Kimura H, Morishima T, Kanegane H, et al. Prognostic factors for chronic active Epstein- Barr virus infection. J Infect Dis, 2003; 187(4): 527-533.
  • 8Kimura H, noshino Y, Hara S, et al. Differences between T cell-type and natural kilter ceil- type chronic active Epstein-Barr virus in-fection. J Infect Dis, 2005; 191(4): 531.
  • 9Gotoh K, Ito Y, Shibata-Watanabe Y, et al. Clinical and virological characteristics of 15 patients with chronic active Epstein-Barr virus infection treated with hematopoietic stem cell transplantation. ClinInfect Dis, 2008; 46(10): 1525 -1534.
  • 10Arai h, Nogami A, Imadome KI, et al. Sequential monitoring of serum IL-6, TNF-:, and IFN- y levels in a CAEBV patient treated by plasma exchange and immunochemotherapy. Int J nematol, 2012; 96(5): 669-673.

共引文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部